Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-tumor immunotherapy based on dendritic cells].

M Toungouz1, M Lambermont, T Velu

  • 1Unité de thérapie cellulaire et moléculaire, Département d'immunologie-hématologie-transfusion, université libre de Bruxelles (ULB).

Journal De La Societe De Biologie
|September 4, 2001
PubMed
Summary

Cancer immunotherapy using dendritic cells (DC) loaded with tumor-associated antigens (TAA) is safe and induces TAA-specific responses. Subcutaneous IL-2 administration promoted long-lasting IL-5 production, with clinical responses in one-third of patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DISPEL: A Python Framework for Developing Measures From Digital Health Technologies.

IEEE open journal of engineering in medicine and biology·2024
Same author

Element Specificity of Transient Extreme Ultraviolet Magnetic Dichroism.

Physical review letters·2020
Same author

Magneto-Optical Functions at the 3p Resonances of Fe, Co, and Ni: Ab initio Description and Experiment.

Physical review letters·2019
Same author

Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis.

European journal of neurology·2010
Same author

[Brant goose colonies near snowy owls: internest distances in relation to lemming and arctic fox abundance].

Izvestiia Akademii nauk. Seriia biologicheskaia·2008
Same author

[First trimester medical abortion: a good method that is seldom used in The Netherlands].

Nederlands tijdschrift voor geneeskunde·2006

Area of Science:

  • Immunology
  • Oncology
  • Cell Therapy

Background:

  • Dendritic cells (DC) loaded with tumor-associated antigens (TAA) represent a promising cancer immunotherapy strategy.
  • Pilot clinical trials were conducted to evaluate the safety and immunogenicity of TAA-loaded autologous DC.

Purpose of the Study:

  • To assess the safety and immunological effects of TAA-loaded autologous DC in cancer patients.
  • To investigate the impact of subcutaneous (s.c.) IL-2 administration on immune responses.

Main Methods:

  • Three pilot clinical trials were performed using TAA-loaded autologous DC.
  • Immunological endpoints were measured, including TAA-specific IFN-gamma and IL-5 production.
  • Clinical responses were monitored in patients receiving the therapy.

Related Experiment Videos

Main Results:

  • The TAA-loaded DC approach was found to be safe.
  • Potent, but transient, TAA-specific IFN-gamma responses were induced.
  • Subcutaneous IL-2 administration led to long-lasting TAA-specific IL-5 production.
  • Approximately one-third of patients showed clinical responses.

Conclusions:

  • TAA-loaded autologous DC immunotherapy is safe and can elicit TAA-specific immune responses.
  • Combining DC therapy with s.c. IL-2 may enhance immune response duration and quality.
  • Future strategies involve novel DC types and tumor cell-DC hybrids for improved efficacy.